Crossref
Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer
Iranian Journal of Blood and Cancer · 2022
DOI: 10.58209/ijbc.14.2.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Masoumeh Mohammadi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mohammadi, M., & hedayati, M. (2022). Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.2.68
Vancouver
Mohammadi M, hedayati M. Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.2.68
BibTeX
@article{Mohammadi2022,
author = {Mohammadi, Masoumeh and hedayati, mehdi},
title = {Visfatin: an adipokine that plays a crucial role in increasing the risk of cancer},
journal = {Iranian Journal of Blood and Cancer},
year = {2022},
doi = {10.58209/ijbc.14.2.68}
}
EUVIMED